Repligen (RGEN) Notes Payables (2017 - 2024)

Repligen (RGEN) has 8 years of Notes Payables data on file, last reported at $69.5 million in Q2 2024.

• Notes Payables for Q2 2024 came in at $69.5 million, down 75.67% year-over-year; the trailing twelve-month figure through Jun 2024 was $69.5 million (down 75.67% YoY), and the FY2023 annual result was $69.5 million, down 75.6% from the prior year.
• Notes Payables steadied at $69.5 million in Q2 2024 per RGEN's latest filing, from $69.5 million in the prior quarter.
• Over five years, Notes Payables peaked at $286.0 million in Q3 2023 and troughed at $69.5 million in Q4 2023.
• A 5-year average of $229.9 million and a median of $255.3 million in 2021 frame the typical range for Notes Payables.
• The sharpest annual moves came in 2022 and 2024: Notes Payables advanced 14.89% in 2022, then plunged 75.67% in 2024.
• A 5-year view of Notes Payables shows it stood at $243.7 million in 2020, then advanced by 4.73% to $255.3 million in 2021, then rose by 11.5% to $284.6 million in 2022, then slumped by 75.6% to $69.5 million in 2023, then grew by 0.04% to $69.5 million in 2024.
• Business Quant data shows RGEN's Notes Payables at $69.5 million in Q2 2024, $69.5 million in Q1 2024, and $69.5 million in Q4 2023.